Pediatric Drugs

Papers
(The median citation count of Pediatric Drugs is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Diagnosis of Serious Conditions Delayed in Association with Ondansetron Treatment for Vomiting in the Pediatric Emergency Department77
Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives66
Alirocumab: Pediatric First Approval56
Treatment Options for Alopecia Areata in Children and Adolescents55
Gentamicin Pharmacokinetics in Neonates Undergoing Therapeutic Hypothermia for Hypoxic Ischemic Encephalopathy53
Acknowledgement to Referees51
Puzolcabtagene Autoleucel: Pediatric First Approval38
Optimizing Drug Selection in Children with Multiple Sclerosis: What Do We Know and What Remains Unanswered?35
Perioperative Indications for Gabapentinoids in Pediatrics: A Narrative Review27
Guselkumab: Pediatric First Approval26
Managing Lupus Nephritis in Children and Adolescents25
Prevalence and Temporal Trends of Attention Deficit Hyperactivity Disorder Medication Fills During Pregnancy and Breastfeeding in Denmark24
Recent Advances in the Management of Seizures in Children24
History and Current Status of Growth Hormone Treatment in Children23
Commercial Versus Compounded Preparations in Pediatric Ophthalmology22
Vedolizumab Versus Other Biologics and the Risk of Venous Thromboembolism in Patients with Pediatric-Onset Inflammatory Bowel Diseases: A Target Trial Emulation Study21
Acute Phase Reaction After First Neridronate Infusion in Children with Osteogenesis Imperfecta: An Analysis Based on Questionnaire Data from 65 Patients20
Intranasal Analgesia in Preterm and Term Neonates19
A New Perspective on Drugs for Duchenne Muscular Dystrophy: Proposals for Better Respiratory Outcomes and Improved Regulatory Pathways19
New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products18
Safety and Effectiveness of Pain Medications for Migraine Management During Pregnancy and Lactation18
Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents17
Real-World Data on the Use of Sirolimus in Asian Children with Vascular Malformations17
Authors’ Reply to Fatima Comment on “Cardioprotective Effect of Nigella sativa in Pediatric Patients with Type 1 Diabetes Mellitus: A Randomized Controlled Study”17
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management16
Improving Methylphenidate Titration in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): A Randomized Controlled Trial Using Placebo-Controlled Titration Implemented in Clinical Practice16
Impact of β-Blockers on the Risk of Low-Birth-Weight Infants in Women with Long QT Syndrome or Marfan Syndrome: A Single-Center Retrospective Study from 2008 to 2022 in a Tertiary Care Center16
Low-Dose Remifentanil in Preterm Cesarean Section with General Anesthesia: A Randomized Controlled Trial15
Pharmacokinetics and Safety of Endotracheal Lidocaine for Endotracheal Intubation in Critically Ill Children15
Pediatric Treatment-Resistant Obsessive Compulsive Disorder: Treatment Options and Challenges15
Learning-Based Models for Predicting IVIG Resistance and Coronary Artery Lesions in Kawasaki Disease: A Review of Technical Aspects and Study Features15
Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients15
Recent Developments in the Treatment of Pediatric Distal Renal Tubular Acidosis15
Inotuzumab Ozogamicin: First Pediatric Approval15
Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date14
Dose Rationale of Nasal Glucagon in Japanese Pediatric Patients with Diabetes Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation14
Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients14
Long-Term Safety of Anti-Interleukin-1 Medications in Children with Rheumatic Diseases: a Systematic Review13
Antipsychotic Medications for Delirium Treatment in the Pediatric Intensive Care Unit: A Systematic Review13
Oral Ibuprofen for the Treatment of PDA in Preterm Neonates: Urgent Need for a Safer Alternative to Hyperosmolar Formulations13
Doxecitine and Doxribtimine: First Approval13
Current Treatment Modalities for Urea Cycle Disorders13
Targeted Treatments for Myasthenia Gravis in Children and Adolescents12
Impact of the Time to Initiation of Indomethacin or Ibuprofen on Patent Ductus Arteriosus Closure Rates12
Toward Optimal Treatment Outcomes in New-Onset Polyarticular-Course Juvenile Idiopathic Arthritis12
Levetiracetam Versus Fosphenytoin Infusions as Second-Line Treatment for Pediatric Status Epilepticus: A Multicenter Study Examining Effectiveness, Tolerability, and Ease of Use12
Off-Label Use of Anakinra in Inflammatory Conditions in Neonates and Infants Up to 3 Months of Age: A Case Series and a Review of the Literature12
Emerging Treatments in Neonatal Fungal Infections: Progress and Prospects12
An Update of Pharmacological Management in Children with Functional Constipation12
Optimizing Antifungal Therapy for Pediatric Tinea Capitis: A Narrative Review of Species-Specific Efficacy, Dosing Strategies, and Clinical Implications11
Adverse Event Profile of First-line Drugs for Treating Patent Ductus Arteriosus in Neonates: A Disproportionality Analysis Study of USFDA Adverse Event Reporting System11
Population Pharmacokinetics and Dose Optimization of Piperacillin in Infants and Children with Pneumonia11
Emerging Treatments for Childhood Interstitial Lung Disease10
Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors10
Toxicity Spectrum of Anti-GD2 Immunotherapy: A Real-World Study Leveraging the US Food and Drug Administration Adverse Event Reporting System10
Mechanistic Links Between Obesity and Airway Pathobiology Inform Therapies for Obesity-Related Asthma10
Comparison of Deep and Moderate Neuromuscular Blockade for Major Laparoscopic Surgery in Children: A Randomized Controlled Trial10
Fixed Dosing of Leuprolide Acetate, a GnRH Agonist, in Children with Central Precocious Puberty: A Population Pharmacokinetic Justification9
Effectiveness and Safety of Ustekinumab in Pediatric Ulcerative Colitis: A Multi-center Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN9
Correction: European Society for Developmental Perinatal and Paediatric Pharmacology Congress, June 25 – 27, 2025, Nijmegen, The Netherlands9
Adverse Drug Reactions in Children with Congenital Heart Disease: A Scoping Review9
Effective Sirolimus Use in Prenatal and Postnatal Management of Symptomatic Extensive Congenital Capillary-Lymphatic-Venous Malformations (CLVMs): A Report of Two Cases9
Prescription Trends for Primary Headache in Children and Adolescents in China During 2019–2023: A Retrospective Study9
Dual-Targeted Therapy in Pediatric Inflammatory Bowel Disease: A Comprehensive Review9
Dosing and Discontinuation of Methylphenidate Medication in Relation to Weight Status in Children and Adolescents9
Neuroimaging as a Tool for Advancing Pediatric Psychopharmacology9
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A Systematic Review9
Optimising Paediatric HIV Treatment: Recent Developments and Future Directions8
Comparison of Different Doses of Oral and Ocular Propranolol for Retinopathy of Prematurity: A Network Meta-Analysis8
Advances in Management of Eosinophilic Esophagitis in Pediatrics8
Personalized Dosing of Medicines for Children: A Primer on Pediatric Pharmacometrics for Clinicians8
Effect of Lactoferrin in Obese Children and Adolescents with Metabolic Dysfunction-Associated Steatotic Disease: A Randomized Controlled Study8
Developing CAR T-Cell Therapies for Pediatric Solid Tumors8
Treatment Options for Juvenile Pityriasis Rubra Pilaris8
Phentermine/Topiramate: Pediatric First Approval8
Clozapine in Child and Adolescent Psychiatry8
Oral Lamivudine for Extended HIV Postnatal Prophylaxis8
Cardioprotective Effect of Nigella sativa in Pediatric Patients with Type 1 Diabetes Mellitus: A Randomized Controlled Study8
Macitentan in the Young—Mid-term Outcomes of Patients with Pulmonary Hypertensive Vascular Disease treated in a Pediatric Tertiary Care Center8
Current and Emerging Therapies for Prevention and Treatment of Bronchopulmonary Dysplasia in Preterm Infants8
Copper Histidinate: Pediatric First Approval8
Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update8
Topical Management of Pediatric Psoriasis: A Review of New Developments and Existing Therapies7
Ganaxolone: A Review in Epileptic Seizures Associated with Cyclin-Dependent Kinase-Like 5 Deficiency Disorder7
Juvenile Dermatomyositis: Updates in Pathogenesis and Biomarkers, Current Treatment, and Emerging Targeted Therapies7
A Multi-Center Evaluation of the Pharmacokinetics and Safety of Intravenous Ibuprofen in Infants 1–6 Months of Age7
A Retrospective Review of Baclofen Treatment for Children with Rumination Syndrome at a Single Center7
Macitentan: Pediatric First Approval7
Treatment Options in Pediatric Behçet’s Disease7
Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey7
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review7
Extrapolating Guselkumab Efficacy to Juvenile Psoriatic Arthritis from Adult Psoriatic Arthritis and Adult and Pediatric Psoriasis Data7
21‑Valent Pneumococcal Conjugate Vaccine V116 (CAPVAXIVE®): Pediatric First Approval6
Efficacy and Safety of Proactive Therapy with 2% Crisaborole Ointment in Children with Mild-to-Moderate Atopic Dermatitis: A Randomized Controlled Study6
Effectiveness and Safety of IL-17A Inhibitors in Pediatric Psoriasis: A Real-World, Multicenter, International Study6
Efficacy and Safety of Wound Catheter Infusion with Ropivacaine After Abdominal Surgery in Children Aged < 1 Year: A Randomized Controlled Trial6
Correction to: Viloxazine: Pediatric First Approval6
Efficacy and Safety of the Adjuvant Use of Probiotic Bacillus clausii Strains in Pediatric Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study5
Authors’ Reply to Reed and Colleagues’ Comment on “Role of mTOR Inhibitors in Pediatric Liver Transplant Recipients: A Systematic Review”5
A Review of Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease in Neonates and Infants5
Paediatric Drug Development in China: Current Status and Future Prospects5
Acknowledgement to Referees5
Impact of Dexmedetomidine Infusion on Opioid and Benzodiazepine Doses in Ventilated Pediatric Patients in the Cardiac Intensive Care Unit5
Epinephrine Underuse for Anaphylaxis in Infants and Toddlers: A Practical Review for Pediatricians5
Risks of Undertreatment and Overtreatment in Pediatric Inflammatory Bowel Disease: Navigating the Balance5
Antiretroviral Options and Treatment Decisions During Pregnancy5
Ferric Maltol: Pediatric First Approval5
Enteral and Parenteral Treatment with Caffeine for Preterm Infants in the Delivery Room: A Randomised Trial5
Pharmacokinetics in Critically Ill Children with Acute Kidney Injury4
The Future of Advanced Therapies for Pediatric Crohn’s Disease4
Medulloblastoma: Current Standard of Care and Future Treatment Opportunities4
Therapeutic Drug Monitoring of Antimicrobial Drugs in Children with Cancer: A New Tool for Personalized Medicine4
Ibrutinib: Pediatric First Approval4
Ceftazidime/Avibactam for the Treatment of Infections in Children: A Case Series of Real-World Use4
A Narrative Review of Pain in Pediatric Oncology: The Opioid Option for Procedural and Surgical Pain4
Safety and Efficacy of Oral Ferric Maltol and Ferrous Sulfate for Iron Deficiency Anemia in Infants, Children and Adolescents: A Multicenter Randomized Trial4
Big Data in the Assessment of Medication Safety in Pregnancy: Opportunities and Challenges4
Antibiotics for Paediatric Community-Acquired Pneumonia: What is the Optimal Course Duration?4
Therapeutic Drug Monitoring of Voriconazole in Critically Ill Pediatric Patients: A Single-Center Retrospective Study4
Pharmacotherapy for Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Childhood Cancer Survivors4
Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015)4
Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapol4
How Consistent are Anti-Infective Drug Dosing Recommendations Across Three European Paediatric Formularies?4
Population Pharmacokinetics of Adalimumab in Juvenile Idiopathic Arthritis Patients: A Retrospective Cohort Study Using Clinical Care Data4
Neurological Adverse Effects of Antipsychotic Medication in Children and Young People4
Pediatric Drugs, Accelerated Approval, and Prospects for Reform4
0.21233415603638